[Management of patients with hematological malignancies in outbreak areas of COVID-19 epidemic: our experience at Wuhan Tongji Hospital]

Zhonghua Xue Ye Xue Za Zhi. 2020 Jul 14;41(7):612-614. doi: 10.3760/cma.j.issn.0253-2727.2020.2020.07.016.

[Article in Chinese]

Authors

Y Xiao¹, Y Cao¹, L Huang¹, M Zheng¹, F K Meng¹, W Huang¹, C R Li¹, M Huang¹, Y C Zhang¹, D H Zhang¹, J N Deng¹, L Meng¹, H Y Sun¹, Y Tang¹, D J Li¹, Y Wan¹, L Xu¹, J F Zhou¹

Affiliation

¹ Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

PMID: 32810973
PMCID: PMC7449773
DOI: 10.3760/cma.j.issn.0253-2727.2020.2020.07.016

No abstract available

MeSH terms

Betacoronavirus
COVID-19
China
Coronavirus Infections / epidemiology*
Hematologic Neoplasms / therapy*
Humans
Pandemics
Pneumonia, Viral / epidemiology*
SARS-CoV-2